Evidence map›Paper›PMID 32882815›Full record

ArticleChildren (Basel, Switzerland)2020

ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study.

Ahlia Sekkarie, Jean A Welsh, Kate Northstone, Catherine E Cioffi, Aryeh D Stein, Janet Figueroa, Usha Ramakrishnan, Miriam B Vos

Open access · goldAbstract read
In one paragraph

Article in Children (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ahlia SekkarieLaney Graduate School, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0002-8419-5188
Jean A WelshLaney Graduate School, Emory University, Atlanta, GA 30322, USA.
Kate NorthstonePopulation Health Science, Bristol Medical School, Bristol BS8 2BN, UK.
Catherine E CioffiDepartment of Pediatrics, Emory School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0002-8402-0118
Aryeh D SteinLaney Graduate School, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0003-1138-6458
Janet FigueroaDepartment of Pediatrics, Emory School of Medicine, Atlanta, GA 30322, USA.
Usha RamakrishnanHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
Miriam B VosLaney Graduate School, Emory University, Atlanta, GA 30322, USA.
Emory University · USAt Bristol · GB

Funding

Medical Research Council G0801456Medical Research Council G9815508Medical Research Council MC_PC_15018Medical Research Council MC_PC_19009Medical Research Council MR/L022206/1UK Medical Research Council MR/L022206/1, G0801456UK Medical Research Council and Wellcome 217065/Z/19/Z
6 · The paper itself

Abstract

(1) Background: Alanine aminotransferase (ALT) is used to screen for non-alcoholic fatty liver disease (NAFLD) in children; however, the optimal age to commence screening is not determined. Our objective was to describe whether ALT trends from 9-24 years were associated with hepatic steatosis at 24 years in a population-based UK cohort. (2) Methods: The sample included 1156 participants who were assessed for hepatic steatosis at 24 years and had at least two ALT measurements at 9, 15, 17, and/or 24 years. Controlled attenuation parameter scores were used to assess steatosis (low (<248 dB/m), mild/moderate (248-279 dB/m), severe (>279 dB/m)). Sex-stratified mixed-effects models were constructed to assess the liver enzyme trends by steatosis level. (3) Results: The final sample was 41.4% male and 10.4% had severe steatosis. In both sexes, ALT trends from 9 to 24 years differed in those with low vs. severe steatosis at 24 years (

Indexed as

ALSPACALTchildhoodlongitudinalNAFLD

Identifiers

PMID32882815
PMCPMC7552746
OpenAlexW3082220352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.